Literature DB >> 11298228

Establishment of orally-administered Lactobacillus gasseri SBT2055SR in the gastrointestinal tract of humans and its influence on intestinal microflora and metabolism.

S Fujiwara1, Y Seto, A Kimura, H Hashiba.   

Abstract

AIMS: To investigate the fate of a streptomycin-rifampicin-resistant variant of Lactobacillus gasseri SBT2055 (LG2055SR) and the influence of its oral administration on the composition and metabolism of the intestinal microflora. METHODS AND
RESULTS: Intestinal passage of LG2055SR was monitored by a combination of selection with antibiotics and identification by a randomly amplified polymorphic DNA (RAPD)-PCR
METHOD: Composition of intestinal microflora was analysed by the method developed by Mitsuoka et al. (1965, 1974). Establishment of orally-administered LG2055SR in the human intestine was confirmed in this study. LG2055SR ingestion specifically lowered faecal populations of Staphylococcus and faecal contents of p-cresol.
CONCLUSION: LG2055SR and its parent strain, LG2055, are considered to be appropriate candidates for probiotics. SIGNIFICANCE AND IMPACT OF THE STUDY: It is clarified that LG2055SR has the ability to establish in the human gastrointestinal tract and alters the composition and metabolism of the intestinal microflora and physical characteristics of faeces.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11298228     DOI: 10.1046/j.1365-2672.2001.01251.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  23 in total

1.  Variation of microbiological and biochemical parameters in the faeces of two healthy people over a 15 day period.

Authors:  Susana Delgado; Adolfo Suárez; Luis Otero; Baltasar Mayo
Journal:  Eur J Nutr       Date:  2004-10-08       Impact factor: 5.614

2.  Effect of Lactobacillus gasseri BNR17 on irritable bowel syndrome: a randomized, double-blind, placebo-controlled, dose-finding trial.

Authors:  Ji Yeon Kim; Yeo Jin Park; Hyo Jin Lee; Min Young Park; Oran Kwon
Journal:  Food Sci Biotechnol       Date:  2017-12-12       Impact factor: 2.391

Review 3.  Biodiversity of Intestinal Lactic Acid Bacteria in the Healthy Population.

Authors:  Marika Mikelsaar; Epp Sepp; Jelena Štšepetova; Epp Songisepp; Reet Mändar
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

4.  Lactobacillus strain ecology and persistence within broiler chickens fed different diets: identification of persistent strains.

Authors:  David P Stephenson; Robert J Moore; Gwen E Allison
Journal:  Appl Environ Microbiol       Date:  2010-08-06       Impact factor: 4.792

5.  Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice.

Authors:  Masaya Miyoshi; Akihiro Ogawa; Satoshi Higurashi; Yukio Kadooka
Journal:  Eur J Nutr       Date:  2013-08-06       Impact factor: 5.614

6.  Physical properties of lactic acid bacteria influence the level of protection against influenza infection in mice.

Authors:  Takumi Watanabe; Kyoko Hayashi; Isao Takahashi; Makoto Ohwaki; Tatsuhiko Kan; Toshio Kawahara
Journal:  PLoS One       Date:  2021-05-18       Impact factor: 3.240

7.  Lactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects.

Authors:  Akihiro Ogawa; Toshiya Kobayashi; Fumihiko Sakai; Yukio Kadooka; Yoshihiro Kawasaki
Journal:  Lipids Health Dis       Date:  2015-03-20       Impact factor: 3.876

8.  Oral administration of Lactobacillus gasseri SBT2055 is effective for preventing influenza in mice.

Authors:  Yosuke Nakayama; Tomohiro Moriya; Fumihiko Sakai; Noriko Ikeda; Takuya Shiozaki; Tomohiro Hosoya; Hisako Nakagawa; Tadaaki Miyazaki
Journal:  Sci Rep       Date:  2014-04-10       Impact factor: 4.379

9.  Pre-, pro-, and synbiotics: do they have a role in reducing uremic toxins? A systematic review and meta-analysis.

Authors:  Megan Rossi; Kerenaftali Klein; David W Johnson; Katrina L Campbell
Journal:  Int J Nephrol       Date:  2012-12-19

10.  Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects.

Authors:  Akihiro Ogawa; Yukio Kadooka; Ken Kato; Bungo Shirouchi; Masao Sato
Journal:  Lipids Health Dis       Date:  2014-02-19       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.